Fresh analysis indicates that people who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who end traditional diet and exercise regimens.
Published data in a leading medical journal points out that while obese people frequently drop substantial amounts of their body weight while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month once they quit.
"People buying these drugs must be cognizant of the potential of rapid weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment weight in about one and a half years.
Weighing Therapies
The research, which reviewed dozens of trials involving thousands of participants, compared the outcomes of GLP-1 agonists with conventional dieting.
Researchers point out that individuals who shed pounds through dieting usually have a slower creep back—approximately 0.1 kg a month—once they finish.
The Reason for the Fast Regain
Experts believe the way of the drugs explains the amplified weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations far above than normal might result in the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement results in appetite is no longer kept in check, making excessive eating far more likely."
A Lifelong Disease?
Health authorities advise the injections for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, considering the significant potential of relapse, the treatment is often ongoing.
This perspective is echoed by drug manufacturers, who note that the results "highlight the long-term character of excess weight," akin to managing conditions like high blood pressure.
Patient Experiences
People who have discontinued the jabs report a sudden resurgence of cravings.
"I experienced a trigger that goes on and I was suddenly starving," said an individual.
The struggle is exacerbated if users have not adopted sustainable lifestyle or habit modifications during therapy.
Significant Interest
Recent estimates suggest that a significant number of people in the UK have tried these injections in the past year, with desire remaining high.
- Adoption is greater among females than men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than public health services.
Ultimately, experts stress that while these medications are effective tools for shedding pounds, they are not a permanent fix and long-term success likely depends on ongoing lifestyle support.
